UnitedHealth tops Q2 EPS and raises FY26 guidance on CNBC
UnitedHealth Group reports adjusted Q2 EPS of $6.38 and GAAP EPS of $6.04, with revenue $112.03B, and issues FY26 guidance above estimates on CNBC’s Final Trades.
On CNBC’s “ Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, picked UnitedHealth Group Inc (NYSE: UNH ). Lending support to his choice, UnitedHealth Group, on July 16, reported better-than-expected second-quarter financial results and issued FY26 guidance above estimates. 86. 83 billion.
04 per share. Kevin Simpson, Capital Wealth Planning CEO, named Visa Inc (NYSE: V ) as his final trade. 23, according to Pro data. 39 billion.
Don’t forget to check out our premarket coverage here Jim Lebenthal, partner and chief market strategist at Cerity Partners, recommended Lockheed Martin Corp (NYSE: LMT ). Supporting his view, Citigroup analyst John Godyn, on Aug. 13, maintained a Buy on Lockheed Martin and raised the price target from $641 to $691. 73 on Friday.
15 during the session. 68 on Friday. Photo via Shutterstock